CAL
FBT icon

Capital Analysts LLC’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Capital Analysts LLC’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$56K Buy
227
+64
+39% +$13.8K ﹤0.01% 964
2026
Q1 		$32K Hold
163
– – ﹤0.01% 1025
2025
Q4 		$34K Hold
163
– – ﹤0.01% 999
2025
Q3 		$29K Buy
163
+45
+38% +$7.66K ﹤0.01% 989
2025
Q2 		$19K Sell
118
-300
-72% -$47.8K ﹤0.01% 1028
2025
Q1 		$71K Buy
+418
New +$72.6K ﹤0.01% 719
2024
Q3 		– Sell
-1,557
Closed -$240K – 1325
2024
Q2 		$240K Hold
1,557
– – 0.01% 433
2024
Q1 		$239K Hold
1,557
– – 0.01% 412
2023
Q4 		$246K Sell
1,557
-100
-6% -$14.4K 0.01% 395
2023
Q3 		$243K Sell
1,657
-1,757
-51% -$268K 0.01% 372
2023
Q2 		$523K Sell
3,414
-50
-1% -$7.8K 0.03% 288
2023
Q1 		$537K Sell
3,464
-90
-3% -$14.1K 0.03% 287
2022
Q4 		$548K Sell
3,554
-179
-5% -$26.4K 0.03% 284
2022
Q3 		$493K Buy
3,733
+1,721
+86% +$241K 0.03% 270
2022
Q2 		$273K Hold
2,012
– – 0.02% 313
2022
Q1 		$300K Hold
2,012
– – 0.02% 307
2021
Q4 		$326K Hold
2,012
– – 0.02% 301
2021
Q3 		$334K Hold
2,012
– – 0.02% 296
2021
Q2 		$347K Sell
2,012
-4,360
-68% -$720K 0.02% 283
2021
Q1 		$1.02M Sell
6,372
-3,661
-36% -$627K 0.07% 199
2020
Q4 		$1.69M Buy
10,033
+45
+0.5% +$7.3K 0.15% 125
2020
Q3 		$1.57M Buy
9,988
+328
+3% +$53.6K 0.15% 120
2020
Q2 		$1.62M Buy
9,660
+1,775
+23% +$279K 0.17% 109
2020
Q1 		$1.03M Buy
7,885
+7,828
+13,733% +$1.12M 0.13% 138
2019
Q4 		$8K Sell
57
-341
-86% -$46.8K ﹤0.01% 571
2019
Q3 		$49K Buy
398
+57
+17% +$7.59K 0.01% 387
2019
Q2 		$48K Hold
341
– – 0.01% 374
2019
Q1 		$51K Buy
+341
New +$49.1K 0.01% 342

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Capital Analysts LLC's FBT Position: Q2 2026 in Review

Capital Analysts LLC increased its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 39% in Q2 2026, buying an estimated $13.8K and bringing the position to 227 shares worth $56K. The position accounts for ﹤0.01% of the portfolio, ranked #964.

Capital Analysts LLC first reported a position in FBT in Q1 2019 and has held it in 28 quarters since. The position peaked at $1.69M in Q4 2020. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Capital Analysts LLC held 227 shares of First Trust NYSE Arca Biotechnology Index Fund worth $56K as of Q2 2026.
  • Capital Analysts LLC bought 64 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $13.8K.
  • First Trust NYSE Arca Biotechnology Index Fund made up ﹤0.01% of Capital Analysts LLC's portfolio in Q2 2026, its #964 holding.
  • Capital Analysts LLC first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and has held it in 28 quarters since.
  • Capital Analysts LLC's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.69M in Q4 2020.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Capital Analysts LLC's 13F filing for Q2 2026, filed 5 Aug 2026.